These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 9004603)
41. Interaction between allopurinol and copper: possible role in myocardial protection. Malkiel S; Har-el R; Schwalb H; Uretzky G; Borman JB; Chevion M Free Radic Res Commun; 1993; 18(1):7-15. PubMed ID: 8349148 [TBL] [Abstract][Full Text] [Related]
42. Kyrle's disease successfully treated with allopurinol. Shih CJ; Tsai TF; Huang H; Ko WC; Hung CM Int J Dermatol; 2011 Sep; 50(9):1170-2. PubMed ID: 22126887 [No Abstract] [Full Text] [Related]
43. Clastogenic factor in ischemia-reperfusion injury: protective effect of allopurinol. Emerit I; Fabiani JN Basic Life Sci; 1988; 49():863-7. PubMed ID: 3266923 [No Abstract] [Full Text] [Related]
44. Allopurinol in ischemia--reperfusion injury of heart. Emerit I; Fabiani JN Adv Exp Med Biol; 1990; 264():367-72. PubMed ID: 2244515 [No Abstract] [Full Text] [Related]
45. Antioxidant therapy--a new therapeutic option for reducing mortality from coronary artery disease. Kendall MJ; Nuttall SL; Martin U J Clin Pharm Ther; 1998 Oct; 23(5):323-5. PubMed ID: 9875678 [No Abstract] [Full Text] [Related]
46. Risk assessment and prevention of contrast-induced nephropathy in patients undergoing coronary angiography. Okumura K; Sone T Intern Med; 2012; 51(6):519-21. PubMed ID: 22449656 [No Abstract] [Full Text] [Related]
47. Ischaemia-reperfusion studies and diabetes mellitus. Canbaz S; Duran E Br J Anaesth; 2003 Jul; 91(1):158; author reply 158-9. PubMed ID: 12821579 [No Abstract] [Full Text] [Related]
48. 1988: Clastogenic factor in ischemia-reperfusion injury during open-heart surgery: protective effect of allopurinol. Updated in 1995. Emerit I; Fabiani JN Ann Thorac Surg; 1995 Sep; 60(3):736-7. PubMed ID: 7677522 [No Abstract] [Full Text] [Related]
49. Prospects for antioxidant therapy in cardiovascular medicine. Hearse DJ Am J Med; 1991 Sep; 91(3C):118S-121S. PubMed ID: 1928202 [No Abstract] [Full Text] [Related]
50. Hyperuricemia increases the risk of acute kidney injury: a systematic review and meta-analysis. Xu X; Hu J; Song N; Chen R; Zhang T; Ding X BMC Nephrol; 2017 Jan; 18(1):27. PubMed ID: 28095822 [TBL] [Abstract][Full Text] [Related]
51. Future directions of vitamin E and its analogues in minimizing myocardial ischemia-reperfusion injury. Mickle DA; Weisel RD Can J Cardiol; 1993; 9(1):89-93. PubMed ID: 8439833 [TBL] [Abstract][Full Text] [Related]
52. Preoperative antioxidant and allopurinol therapy for reducing reperfusion-induced injury in patients undergoing cardiothoracic surgery. Simko LC; Walker JH Crit Care Nurse; 1996 Dec; 16(6):69-73. PubMed ID: 9004603 [TBL] [Abstract][Full Text] [Related]
53. The effects of intracoronary administration of vitamin E on myocardial ischemia-reperfusion injury during coronary artery surgery. Canbaz S; Duran E; Ege T; Sunar H; Cikirikcioglu M; Acipayam M Thorac Cardiovasc Surg; 2003 Apr; 51(2):57-61. PubMed ID: 12730811 [TBL] [Abstract][Full Text] [Related]
54. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting. Sisto T; Paajanen H; Metsä-Ketelä T; Harmoinen A; Nordback I; Tarkka M Ann Thorac Surg; 1995 Jun; 59(6):1519-23. PubMed ID: 7771834 [TBL] [Abstract][Full Text] [Related]
55. The effect of allopurinol on free oxygen radicals in myocardial reperfusion. Fabián J; Popovic Z; Vucinic M Cor Vasa; 1992; 34(5-6):411-20. PubMed ID: 1339712 [TBL] [Abstract][Full Text] [Related]
56. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass. Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834 [TBL] [Abstract][Full Text] [Related]